Depression News

Computer-assisted cognitive behavior therapy had significantly greater effects on depressive symptoms vs. treatment as usual among primary care patients with depression, according to results of a randomized clinical trial.

Timely depression screening increased about 20% among patients after a quality improvement initiative was implemented at their primary care practices, according to findings published in the Journal of Community Health.

Data show that people who survived COVID-19 were more likely to report symptoms of anxiety, depression or both compared with those who did not have a history of the disease.

Sunovion and Otsuka announced the first patient has been randomly assigned in their phase 3 clinical study of non-racemic amisulpride for treating major depressive episodes linked to bipolar I disorder.

Mental health and psychosocial well-being are associated with achieving sustained rheumatoid arthritis remission and treatment response, according to data published in Arthritis Care & Research.

As symptom severity for major depressive disorder and treatment-resistant depression increases, so do costs to health systems, according to a retrospective cohort study published in the Journal of Clinical Psychiatry.

Ketamine provided rapid benefits to hospitalized patients with suicidal ideation; however, more research is needed to determine its long-term impact, according to findings from a French study published in The BMJ.

The collaborative care model was associated with reductions in racial disparities in mental health screening among pregnant and postpartum women, according to recent findings.

Resident physicians had high levels of functionally impairing depressive symptoms during internship year, according to a study published in JAMA Network Open.

Researchers identified variables reported as significant in three or more randomized clinical trials with respect to adolescent depression outcomes, according to results of a scoping review published in JAMA Network Open.